Literature DB >> 22356223

Pain mechanisms in patients with chronic pain.

Diego Fornasari1.   

Abstract

The mechanisms involved in the development of chronic pain are varied and complex. Pain processes are plastic and unrelieved pain may lead to changes in the neural structure involved in pain generation. Nociceptive pain announces the presence of a potentially damaging stimulus that occurs when noxious stimuli activate primary afferent neurons. Neuropathic pain is initiated or caused by a primary lesion or dysfunction in the nervous system resulting from trauma, infection, ischaemia, cancer or other causes such as chemotherapy. The exact mechanisms involved in the pathophysiology of chronic pain are not well understood, but rapid and long-term changes are thought to occur in parts of the central nervous system that are involved in the transmission and modulation of pain following injury. Peripheral and central sensitization of sensory nerve fibres are the primary reasons for hypersensitivity to pain after injury, and mainly occur in inflammatory and neuropathic pain. During these processes the sensation of pain is enhanced as a result of changes in the environment, the nerve fibres and modifications of the functional properties and the genetic programme of primary and secondary afferent neurons. Non-steroidal anti-inflammatory drugs and opioid analgesics are two of the most common classes of drugs used for the treatment of pain. Response to drug treatment shows significant interindividual variability and can lead to side effects. The neurobiological mechanisms that cause pain may account for the different types of pain observed. Identification of these mechanisms may allow us to move from an empirical therapeutic approach to one that it is specifically targeted at the particular mechanisms of the type of pain experienced by an individual patient.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22356223     DOI: 10.2165/11630070-000000000-00000

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  19 in total

1.  New Directions in the Treatment of Chronic Pain: National Pain Strategy Will Guide Prevention, Management, and Research.

Authors:  Susan L Worley
Journal:  P T       Date:  2016-02

Review 2.  Pain pharmacology: focus on opioids.

Authors:  Diego Fornasari
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

3.  Is melatonin the next "new" therapy to improve sleep and reduce pain?

Authors:  Carol A Landis
Journal:  Sleep       Date:  2014-09-01       Impact factor: 5.849

Review 4.  Stress-induced pain: a target for the development of novel therapeutics.

Authors:  Anthony C Johnson; Beverley Greenwood-Van Meerveld
Journal:  J Pharmacol Exp Ther       Date:  2014-09-05       Impact factor: 4.030

5.  Upregulation of neuregulin-1 reverses signs of neuropathic pain in rats.

Authors:  Guojun Wang; Dawei Dai; Xin Chen; Lei Yuan; Aijun Zhang; Youming Lu; Pengqi Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

6.  Clinical applications of neurochemical and electrophysiological measurements for closed-loop neurostimulation.

Authors:  J Blair Price; Aaron E Rusheen; Abhijeet S Barath; Juan M Rojas Cabrera; Hojin Shin; Su-Youne Chang; Christopher J Kimble; Kevin E Bennet; Charles D Blaha; Kendall H Lee; Yoonbae Oh
Journal:  Neurosurg Focus       Date:  2020-07       Impact factor: 4.047

7.  Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse.

Authors:  Wisam Toma; S Lauren Kyte; Deniz Bagdas; Yasmin Alkhlaif; Shakir D Alsharari; Aron H Lichtman; Zhi-Jian Chen; Egidio Del Fabbro; John W Bigbee; David A Gewirtz; M Imad Damaj
Journal:  Neuropharmacology       Date:  2017-02-22       Impact factor: 5.250

Review 8.  Role of estrogen and stress on the brain-gut axis.

Authors:  Yanyan Jiang; Beverley Greenwood-Van Meerveld; Anthony C Johnson; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-06-26       Impact factor: 4.052

Review 9.  Quantitative sensory testing and predicting outcomes for musculoskeletal pain, disability, and negative affect: a systematic review and meta-analysis.

Authors:  Vasileios Georgopoulos; Kehinde Akin-Akinyosoye; Weiya Zhang; Daniel F McWilliams; Paul Hendrick; David A Walsh
Journal:  Pain       Date:  2019-09       Impact factor: 7.926

Review 10.  Utilization of Intravenous Lidocaine Infusion for the Treatment of Refractory Chronic Pain.

Authors:  Janell Tully; Jai Won Jung; Anjana Patel; Alyson Tukan; Sameer Kandula; Allen Doan; Farnad Imani; Giustino Varrassi; Elyse M Cornett; Alan David Kaye; Omar Viswanath; Ivan Urits
Journal:  Anesth Pain Med       Date:  2021-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.